Thyroid Diseases Clinical Trial
Official title:
Systematic Administration vs on Demand Administration of Calcium and Vitamin D After Thyroidectomy. A Randomized Control Trial
Transient hypocalcaemia consist the most common postoperative complication after thyroidectomy (10-45%). It may be mild and subclinical or cause mild or severe symptoms and may lead to longer hospital stay as well as in discomfort of the patients. For the management oral or intravenous calcium with or without vitamin D administration can be used based on the blood calcium levels and on the symptomatology. The investigators intent to study a new protocol with oral calcium and vitamin D given systematically from the day of operation to assess if this practice can minimize the rate of transient hypocalcaemia and as a consequence minimize the length of stay in the hospital.
Transient hypocalcaemia consist the most common postoperative complication after
thyroidectomy (10-45%). It may be mild and subclinical or cause mild or severe symptoms and
may lead to longer hospital stay as well as in discomfort of the patients. For the management
oral or intravenous calcium with or without vitamin D administration can be used based on the
blood calcium levels and on the symptomatology.
Group A = control group will be managed as usual. Oral or IV supplements of Calcium will be
giver on demand and recorded according to the clinical picture or the biochemical
hypocalcaemia.
Group B= study group will be given systematically from the day of operation a scheme with
oral calcium in the form of 1000ca++mg/tab and oral alfacalcidol in the form of 0.5
micrograms/tb The patients will receive one tablet three times a day oral calcium (3g/d) and
2 tablets , two times a day alfacalcidiol (2 micrograms/d) for the first 5 days. Afterwards
they will be taking 2 tablets a day of oral calcium ( 2g) and 2 tablets a day alfacalcidiol
(1micrograms/d) for another 10 days ( total 15 days) The investigators intent to minimize the
immediate transient hypocalcaemia rate and give time to the parathyroids which may have been
bruised or have compromised function initially to recover by day 15.
The 1st and 2nd postoperative day the invastigators are going to take blood samples and
assess the 25 hydroxy vit D, the parathyroid hormone (PTH) and the Ca++. The investigators
will also assess the calcium levels after the first week and if necessary ( in cases with
longstanding hypocalcaemia ) in later day.
The patients will be discharged from the hospital the day after the operation provided the
calcium levels are within normal range and they are completely asymptomatic.
In case of symptoms after the discharge the patients will be managed accordingly and this
will be recorded in the records of each patient
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05975866 -
The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato
|
N/A | |
| Terminated |
NCT04589884 -
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
|
||
| Completed |
NCT00569920 -
Nausea and Pain Prophylaxis During Thyroid Surgery
|
N/A | |
| Recruiting |
NCT05917067 -
Fluorescence Imaging of the Parathyroid Glands of Children
|
||
| Completed |
NCT04704349 -
Latest Imaging SPECT System Evaluation Phase 1
|
N/A | |
| Recruiting |
NCT05430139 -
Dried Blood Spot Testing for At Home Health
|
||
| Recruiting |
NCT05635266 -
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
| Completed |
NCT01727973 -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06112340 -
A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05678374 -
Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
|
||
| Not yet recruiting |
NCT04094493 -
Vit D Role in Post Thyroidectomy Hypocalcemia
|
Early Phase 1 | |
| Completed |
NCT03157466 -
Respiratory Muscle Function After Thyroid Hormone Replacement Therapy in Nonthyroidal Illness Syndrome
|
||
| Completed |
NCT04542278 -
Preoperative Steroids in Autoimmune Thyroid Disease
|
Phase 4 | |
| Completed |
NCT04425512 -
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
|
N/A | |
| Recruiting |
NCT05510609 -
Three-dimensional Ultrasonography Thyroid Volume Measurement.
|
N/A | |
| Recruiting |
NCT05412680 -
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)
|
N/A | |
| Completed |
NCT06227819 -
BVA-200 vs BVA-100 Validation Study
|
||
| Completed |
NCT00150033 -
Health-Related Quality of Life for Thyroid Patients
|
Phase 2 | |
| Active, not recruiting |
NCT04351945 -
Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
|
||
| Enrolling by invitation |
NCT04411290 -
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
|